SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-006639
Filing Date
2018-08-07
Accepted
2018-08-07 17:30:05
Documents
70
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20180630x10q.htm 10-Q 1949103
2 EX-10.2 ptgx-20180630ex1029c1683.htm EX-10.2 28237
3 EX-31.1 ptgx-20180630ex31145339b.htm EX-31.1 12356
4 EX-31.2 ptgx-20180630ex312fc7989.htm EX-31.2 13469
5 EX-32.1 ptgx-20180630ex321f47f0d.htm EX-32.1 13743
6 GRAPHIC ptgx20180630ex1029c1683001.jpg GRAPHIC 1871
7 GRAPHIC ptgx20180630ex1029c1683002.jpg GRAPHIC 2761
8 GRAPHIC ptgx20180630ex1029c1683003.jpg GRAPHIC 2199
9 GRAPHIC ptgx20180630ex1029c1683004.jpg GRAPHIC 1425
  Complete submission text file 0001558370-18-006639.txt   6882854

Data Files

Seq Description Document Type Size
10 EX-101.INS ptgx-20180630.xml EX-101.INS 1534435
11 EX-101.SCH ptgx-20180630.xsd EX-101.SCH 46258
12 EX-101.CAL ptgx-20180630_cal.xml EX-101.CAL 43730
13 EX-101.DEF ptgx-20180630_def.xml EX-101.DEF 142902
14 EX-101.LAB ptgx-20180630_lab.xml EX-101.LAB 363824
15 EX-101.PRE ptgx-20180630_pre.xml EX-101.PRE 305064
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 18999217
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences